Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gregory Elliott

Pulmonary circulation

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pulmonary Circulation|December 15, 2022
Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous thromboembolismMark W Dodson, Meghan M Cirulis, C Gregory Elliott
Pulmonary Circulation|June 18, 2020
A novel BMPR2 mutation with widely disparate heritable pulmonary arterial hypertension clinical phenotypeIfeoma Oriaku, Mallory N LeSieur, William C Nichols, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Pulmonary Circulation|May 18, 2019
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implicationsC Gregory Elliott, Eric D Austin, David Badesch, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pulmonary Circulation|December 15, 2022
Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous thromboembolismMark W Dodson, Meghan M Cirulis, C Gregory Elliott
Pulmonary Circulation|June 18, 2020
A novel BMPR2 mutation with widely disparate heritable pulmonary arterial hypertension clinical phenotypeIfeoma Oriaku, Mallory N LeSieur, William C Nichols, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Pulmonary Circulation|May 18, 2019
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implicationsC Gregory Elliott, Eric D Austin, David Badesch, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
Pageof 1